MY 1

Drug Profile

MY 1

Alternative Names: CCRIS 4212; MS-5101; My-1; Mycobacterium bovis bcg extract; Selfenon

Latest Information Update: 22 Jan 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nihon Schering
  • Class Antineoplastics
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Cancer; Lymphoma; Malignant melanoma

Most Recent Events

  • 22 Jan 2007 Discontinued - Preregistration for Cancer in Japan (Injection)
  • 22 Jan 2007 Discontinued - Preregistration for Lymphoma in Japan (Injection)
  • 22 Jan 2007 Discontinued - Preregistration for Malignant melanoma in Japan (Injection)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top